Hack
M, Klein
NK, Taylor
HG. Long-term developmental outcomes of low birth weight infants. Future Child. 1995;5176- 196
Palta
M, Weinstein
MR, McGuinness
G, Gabbert
D, Brady
W, Peters
ME. A population study: mortality and morbidity after availability of surfactant therapy. Arch Pediatr Adolesc Med. 1994;1481295- 1301
Horbar
JD, Wright
EC, Onstad
L.and the National Institute of Child Health and Human Development Neonatal Research Network,
Decreasing mortality associated with the introduction of surfactant therapy: an observational study of neonates weighing 601 to 1300 grams at birth. Pediatrics. 1993;92191- 196
Schwartz
RM, Luby
AM, Scalon
JW, Kellogg
RJ. Effect of surfactant on morbidity, mortality, and resource use in newborn infants weighing 500 to 1500g. N Engl J Med. 1994;3301476- 1480
Hamvas
A, Wise
P, Yang
RK.
et al. The influence of the wider use of surfactant therapy on neonatal mortality among blacks and whites. N Engl J Med. 1996;3341635- 1640
Blitz
RK, Wachtel
RC, Blackmon
L, Berenson-Howard
J. Neurodevelopmental outcome of extremely low birth weight infants in Maryland. Md Med J. 1997;4618- 24
Thompson
RJ
Jr, Gustafson
KE, Oehler
JM, Catlett
AT, Brazy
JE, Goldstein
RF. Developmental outcome of very low birth weight infants at four years of age as a function of biological risk and psychosocial risk. J Dev Behav Pediatr. 1997;1891- 96
Casiro
O, Bingham
W, MacMurray
B.
et al. One-year follow-up of 89 infants with birth weights of 500 to 749 grams and respiratory distress syndrome randomized to two rescue doses of synthetic surfactant or air placebo. J Pediatr. 1995;126
((pt 2))
S53- S60
Ment
LR, Vohr
B, Oh
W.
et al. Neurodevelopmental outcomes at 36 months' corrected age of preterm infants in the Multicenter Indomethacin Intraventricular Hemorrhage Prevention Trial. Pediatrics. 1996;98
((pt 1))
714- 718
Hack
M, Friedman
H, Fanaroff
AA. Outcomes of extremely low birth weight infants. Pediatrics. 1996;98931- 937
Furman
L, Hack
M, Watts
C.
et al. Twenty-month outcome in ventilator-dependent, very low birth weight infants born during the early years of dexamethasone therapy. J Pediatr. 1995;126434- 440
Singer
L, Yamashita
T, Lilien
L, Collin
M, Baley
J. A longitudinal study of developmental outcome of infants with bronchopulmonary dysplasia and very low birth weight. Pediatrics. 1997;100987- 993
Schendel
DE, Stockbauer
JW, Hoffman
HJ, Herman
AA, Berg
CJ, Schramm
WF. Relation between very low birth weight and developmental delay among preschool children without disabilities. Am J Epidemiol. 1997;146740- 749
Saigal
S, Rosenbaum
P, Stoskopf
B.
et al. Comprehensive assessment of the health status of extremely low birth weight children at eight years of age: comparison with a reference group. J Pediatr. 1994;125411- 417
Saigal
S, Feeny
D, Furlong
W, Rosenbaum
P, Burrows
E, Torrance
G. Comparison of the health-related quality of life of extremely low birth weight children and a reference group of children at age eight years. J Pediatr. 1994;125418- 425
Vohr
BR, Msall
ME. Neuropsychological and functional outcomes of very low birth weight infants. Semin Perinatol. 1997;21202- 220
Palta
M, Gabbert
D, Weinstein
MR, Peters
ME. Multivariate assessment of traditional risk factors for chronic lung disease in very low birth weight neonates. J Pediatr. 1991;119285- 292
Palta
M, Sadek
M, Barnet
JH.
et al. Evaluation of criteria for chronic lung disease in surviving very low birth weight infants. J Pediatr. 1998;13257- 63
Weinstein
MR, Peters
ME, Sadek
M, Palta
M. A new radiographic scoring system for bronchopulmonary dysplasia. Pediatr Pulmonol. 1994;18284- 289
Haley
SM, Caster
WJ, Ludlow
LH, Haltiwanger
JT, Andrellos
PJ. Pediatric Evaluation of Disability Inventory (PEDI), Version 1, Development, Standardization and Administration Manual. Boston, Mass New England Medical Center–PEDI Research Group1992;
Stevens
G, Cho
JH. Socioeconomic indexes and the new 1980 census occupational classification scheme. Soc Sci Res. 1985;14142- 168
SAS Institute Inc,
SAS/STAT User's Guide, Version 6. Vols 1 and 24th ed. Cary, NC SAS Institute Inc1989;
Ott
L. An Introduction to Statistical Methods and Data Analysis. Belmont, Calif Wadsworth Publishing Co Inc1977;342
Kleinbaum
DG, Kupper
LL, Muller
KE. Applied Regression Analysis and Other Multivariable Methods. Boston, Mass PWS-KENT Publishing Co1988;149- 151
Jobe
AH, Mitchell
BR, Gunkel
JH. Beneficial effects of the combined use of prenatal corticosteroids and postnatal surfactant on preterm infants. Am J Obstet Gynecol. 1993;168508- 513
White
A, Marcucci
G, Andrews
E, Edwards
K, Long
W. Antenatal steroids and neonatal outcomes in controlled clinical trials of surfactant replacement: the American Exosurf Neonatal Study Group I and the Canadian Exosurf Neonatal Study Group. Am J Obstet Gynecol. 1995;173286- 290
Gunkel
JH, Mitchell
BR. Observational evidence for the efficacy of antenatal steroids from randomized studies of surfactant replacement. Am J Obstet Gynecol. 1995;173281- 285
Vaucher
Y, Merritt
A, Hallman
M, Jarvemaa
A-L, Telsey
AM, Jones
BL. Neurodevelopmental and respiratory outcome after human surfactant treatment. AJDC. 1988;142927- 930
Powell
S, Holt
V, Hickok
D, Easterling
T, Connell
F. Recent changes in delivery site of low-birthweight infants in Washington: impact on birth weight–specific mortality. Am J Obstet Gynecol. 1995;1731585- 1592
Allan
WC, Vohr
B, Makuch
RW, Katz
KH, Ment
LR. Antecedents of cerebral palsy in a multicenter trial of indomethacin for intraventricular hemorrhage. Arch Pediatr Adolesc Med. 1997;151580- 585